Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach.


Journal

Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 08 05 2023
accepted: 11 08 2023
medline: 5 12 2023
pubmed: 14 9 2023
entrez: 13 9 2023
Statut: ppublish

Résumé

To compare safety, technical and clinical outcomes of double vein embolization (DVE) via a trans-jugular approach with liver venous deprivation (LVD) via a trans-hepatic approach. A single-center retrospective analysis was conducted on patients undergoing simultaneous portal and hepatic veins embolization in view of a major hepatectomy (June 2019-November 2022). Hepatic vein embolization was performed either by transjugular plug (DVE) or by transhepatic plug followed by glue injection (LVD). Inclusion criteria were availability of pre-procedural CT scan, and availability of CT scans acquired 10 days and 25 days post-procedure. Comparative data included complication rate, fluoroscopy time, dose area product (DAP), Future Liver Remnant volume and function increase (FLR-V and FLR-F increase, respectively) and clinical outcomes. Thirty-six patients (n = 14 DVE; n = 22 LVD) were included. No baseline significant differences were observed among the two groups. One grade-3 complication (2.8%) was observed in the LVD group; one case of technical failure (2.8%) was observed in the DVE group. Fluoroscopy time and DAP were similar between DVE and LVD (29 ± 17.7 vs. 25 ± 8.2 min, p = 0.97; 105.1 ± 63.5 vs. 143.4 ± 79.5 Gy·cm LVD via transhepatic approach and DVE via transjugular approach seem equally safe and effective. Level of Evidence Level 3, Retrospective Cohort Study.

Identifiants

pubmed: 37704862
doi: 10.1007/s00270-023-03538-3
pii: 10.1007/s00270-023-03538-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1703-1712

Informations de copyright

© 2023. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Références

Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–9.
doi: 10.1016/S1072-7515(98)00301-9 pubmed: 10065820
Schreckenbach T, Liese J, Bechstein WO, Moench C. Posthepatectomy liver failure. Dig Surg. 2012;29:79–85.
doi: 10.1159/000335741 pubmed: 22441624
Garcea G, Ong SL, Maddern GJ. Predicting liver failure following major hepatectomy. Dig Liver Dis. 2009;41:798–806.
doi: 10.1016/j.dld.2009.01.015 pubmed: 19303376
Guiu B, Deshayes E, Panaro F, Sanglier F, Cusumano C, Herrerro A, et al. 99mTc-mebrofenin hepatobiliary scintigraphy and volume metrics before liver preparation: correlations and discrepancies in non-cirrhotic patients. Ann Transl Med. 2021;9:795–795.
doi: 10.21037/atm-20-7372 pubmed: 34268408 pmcid: 8246210
Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803–8.
doi: 10.1007/BF01655244 pubmed: 3022488
Van Lienden KP, Van Den Esschert JW, De Graaf W, Bipat S, Lameris JS, Van Gulik TM, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36:25–34.
doi: 10.1007/s00270-012-0440-y pubmed: 22806245
Yamashita S, Sakamoto Y, Yamamoto S, Takemura N, Omichi K, Shinkawa H, et al. Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases. Ann Surg Oncol. 2017;24:1557–68.
doi: 10.1245/s10434-017-5800-z pubmed: 28188502
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14.
doi: 10.1097/SLA.0b013e31824856f5 pubmed: 22330038
Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, et al. Prediction of mortality after ALPPS Stage-1. Ann Surg. 2015;262:780–6.
doi: 10.1097/SLA.0000000000001450 pubmed: 26583666
Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, et al. Early survival and safety of ALPPS first report of the international ALPPS registry. Ann Surg. 2014;260:829–38.
doi: 10.1097/SLA.0000000000000947 pubmed: 25379854
Guiu B, Chevallier P, Denys A, Delhom E, Pierredon-Foulongne MA, Rouanet P, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol. 2016;26:4259–67.
doi: 10.1007/s00330-016-4291-9 pubmed: 27090112
Laurent C, Fernandez B, Marichez A, Adam JP, Papadopoulos P, Lapuyade B, et al. Radiological simultaneous portohepatic vein embolization (RASPE) before major hepatectomy: a better way to optimize liver hypertrophy compared to portal vein embolization. Ann Surg. 2020;272:199–205.
doi: 10.1097/SLA.0000000000003905 pubmed: 32675481
Guiu B, Quenet F, Panaro F, Piron L, Cassinotto C, Herrerro A, et al. Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes. Hepatobiliary Surg Nutr. 2020;9:564–76.
doi: 10.21037/hbsn.2020.02.06 pubmed: 33163507 pmcid: 7603937
Kobayashi K, Yamaguchi T, Denys A, Perron L, Halkic N, Demartines N, et al. Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: a single center experience. Surg. 2020;167:917–23.
doi: 10.1016/j.surg.2019.12.006
Cassese G, Troisi RI, Khayat S, Quenet F, Tomassini F, Panaro F, et al. Liver venous deprivation versus associating liver partition and portal vein ligation for staged hepatectomy for colo-rectal liver metastases: a comparison of early and late kinetic growth rates, and perioperative and oncological outcomes. Surg Oncol. 2022;43:101812.
doi: 10.1016/j.suronc.2022.101812 pubmed: 35820263
Deshayes E, Piron L, Bouvier A, Lapuyade B, Lermite E, Vervueren L, et al. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy. BMC Cancer. 2020. https://doi.org/10.1186/s12885-020-07065-z .
doi: 10.1186/s12885-020-07065-z pubmed: 32560632 pmcid: 7304136
Korenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B, et al. Dragon 1 protocol manuscript: training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy. Cardiovasc Intervent Radiol. 2022;45:1391–8.
doi: 10.1007/s00270-022-03176-1 pubmed: 35790566 pmcid: 9458562
Mendes Luz JH, Gomes FV, Costa NV, Vasco I, Coimbra E, Luz PM, et al. BestFLR trial: Liver regeneration at CT before major hepatectomies for liver cancer—a randomized controlled trial comparing portal vein embolization with N-butyl-cyanoacrylate plus iodized oil versus polyvinyl alcohol particles plus coils. Radiology. 2021;299:715–24.
doi: 10.1148/radiol.2021204055
Corte AD, Fiorentini G, Ratti F, Cipriani F, Canevari C, Catena M, Gusmini S, Augello L, Palumbo D, Guazzarotti G, Aldrighetti L, De Cobelli F. Combining laparoscopic liver partitioning and simultaneous portohepatic venous deprivation for rapid liver hypertrophy. J Vasc Interv Radiol. 2022;33:525–9.
doi: 10.1016/j.jvir.2022.01.018 pubmed: 35489784
Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–9.
doi: 10.1067/msy.2000.105294 pubmed: 10819059
Cieslak KP, Bennink RJ, de Graaf W, van Lienden KP, Besselink MG, Busch ORC, et al. Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. HPB. 2016;18:773–80.
doi: 10.1016/j.hpb.2016.06.006 pubmed: 27593595 pmcid: 5011085
de Graaf W, van Lienden KP, Dinant S, Roelofs JJTH, Busch ORC, Gouma DJ, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg. 2010;14:369–78.
doi: 10.1007/s11605-009-1085-2 pubmed: 19937195
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6.
doi: 10.1007/s00270-017-1703-4 pubmed: 28584945
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS). Surgery. 2011;149:713–24.
doi: 10.1016/j.surg.2010.10.001 pubmed: 21236455
Di Stefano DR, De Baere T, Denys A, Hakime A, Gorin G, Gillet M, et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology. 2005;234:625–30.
doi: 10.1148/radiol.2342031996 pubmed: 15591428
Shaw CM, Madoff DC. Acute thrombosis of left portal vein during right portal vein embolization extended to segment 4. Semin Intervent Radiol. 2011;28:156–61.
doi: 10.1055/s-0031-1280655 pubmed: 22654253 pmcid: 3193332
Ohkubo M, Nagino M, Kamiya J, Arai T, Nishio H, Nimura Y. Portal and mesenteric vein thrombosis after portal vein embolization in a patient with protein S deficiency. J Hepatobiliary Pancreat Surg. 2004;11:338–41.
doi: 10.1007/s00534-004-0905-8 pubmed: 15549434
Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg. 2009;249:608–16.
doi: 10.1097/SLA.0b013e31819ecc5c pubmed: 19300228

Auteurs

Angelo Della Corte (A)

Department of Radiology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy. a.dellacortetartaglione@gmail.com.
Vita-Salute San Raffaele University, 20132, Milan, Italy. a.dellacortetartaglione@gmail.com.
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy. a.dellacortetartaglione@gmail.com.

Domenico Santangelo (D)

Department of Radiology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.

Luigi Augello (L)

Department of Radiology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.

Francesca Ratti (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, 20132, Milan, Italy.

Federica Cipriani (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, 20132, Milan, Italy.

Carla Canevari (C)

Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy.

Simone Gusmini (S)

Department of Radiology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.

Giorgia Guazzarotti (G)

Department of Radiology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.

Diego Palumbo (D)

Department of Radiology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.
Vita-Salute San Raffaele University, 20132, Milan, Italy.
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.

Arturo Chiti (A)

Vita-Salute San Raffaele University, 20132, Milan, Italy.
Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy.

Luca Aldrighetti (L)

Vita-Salute San Raffaele University, 20132, Milan, Italy.
Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, 20132, Milan, Italy.

Francesco De Cobelli (F)

Department of Radiology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.
Vita-Salute San Raffaele University, 20132, Milan, Italy.
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH